文献速递功能神经外科

基于参数分析评估终纹床核-伏隔核联合脑深部电刺激治疗难治性抑郁症的临床疗效

Parameter-based analysis of clinical efficacy of combined bed nucleus of the stria terminalis-nucleus accumbens deep brain stimulation for treatment-resistant depression.
PubMed 文献 · J Neurosurg · 2024-01-12

该单中心研究纳入2021年3月至2023年5月接受终纹床核(BNST)与伏隔核(NAc)双靶点联合脑深部电刺激(DBS)的23例难治性抑郁症(TRD)患者,末次随访(范围4-24个月)时14例应答(HAMD-17评分改善≥50%),其中7例达到临床缓解(HAMD-17评分≤7)。电极位置分析提示BNST对抑郁症状改善可能比NAc更重要,VTA与BNST重叠体积与HAMD-17评分绝对变化显著相关(左侧ρ=-0.377,p<0.001;右侧ρ=-0.251,p<0.001)。作者认为联合刺激可有效改善抑郁症状,未来需更大规模前瞻性队列验证。

要点

  • 23例TRD患者接受BNST-NAc联合DBS,末次随访14例应答、7例临床缓解。
  • 电极位置分析提示BNST对抑郁症状改善可能比NAc更重要。
  • VTA与BNST重叠体积与HAMD-17绝对变化显著相关(左侧ρ=-0.377,右侧ρ=-0.251)。

核心结论

  • BNST-NAc联合刺激可有效改善TRD患者抑郁症状,其中BNST似乎具有主导治疗效应。
  • 作者指出未来需要更大规模的前瞻性队列来验证联合BNST-NAc DBS的结果。

研究设计与样本

  • 单中心研究,纳入2021年3月至2023年5月接受DBS的23例难治性抑郁症患者。
  • 使用8触点DBS电极,手术路径跨越BNST和NAc靶点。
  • 在各次随访中获取刺激参数及HAMD-17等量表评估的症状严重程度。
  • 评估电极位置准确性、联合刺激效果及相应刺激参数,并使用甜点预测模型评估有效刺激位点。

主要发现

  • 末次随访(范围4-24个月)时14例患者应答(HAMD-17评分改善≥50%),其中7例达到临床缓解(HAMD-17评分≤7)。
  • 电极位置分析提示BNST对抑郁症状改善可能比NAc更重要。
  • VTA与BNST重叠体积与HAMD-17评分绝对变化显著相关(左侧ρ=-0.377,p<0.001;右侧ρ=-0.251,p<0.001)。
  • VTA与BNST重叠体积与HAMD-17评分百分比变化的相关性为左侧ρ=-0.249(p<0.001)、右侧ρ=-0.098(p=0.102)。
  • HAMD-17改善的甜点模型提示VTA与BNST背侧重叠与对抑郁症状的影响相关(t=-4.10,p<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者指出未来需要更大规模的前瞻性队列来验证联合BNST-NAc DBS的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Treatment-resistant depression (TRD) is a severely disabling psychiatric condition that responds poorly to conventional treatments. Deep brain stimulation (DBS) has been proposed for the treatment of patients with TRD in numerous studies. Several deep brain nuclei are considered as potential targets for TRD-DBS, but their clinical efficacy needs further validation. This study carried out dual-target combined stimulation of the bed nucleus of the stria terminalis (BNST) and nucleus accumbens (NAc) to investigate the effectiveness of the treatment for TRD patients. METHODS: An 8-contact DBS electrode was used in the study with a surgical path that crossed the BNST and NAc targets. Stimulation parameters and the corresponding severity of symptoms evaluated by the 17-item Hamilton Depression Rating Scale (HAMD-17) and other scales were obtained at each follow-up. The accuracy of electrode positions, the effect of combined stimulation, and the corresponding stimulation parameters were evaluated. Sweet spot prediction models were used to assess the effective stimulation sites in the treatment. RESULTS: The study included 23 TRD patients undergoing DBS at a single center from March 2021 to May 2023. At the last follow-up (range 4-24 months), 14 patients had responded to the treatment (HAMD-17 score improved ≥ 50%), 7 of whom had achieved clinical remission (HAMD-17 score ≤ 7). Electrode position analysis suggested that the BNST may be more important for the improvement of depressive symptoms than the NAc. Overlapped volumes of volume of tissue activated (VTA) and BNST were significantly correlated with absolute (ρleft = -0.377, p < 0.001; ρright = -0.251, p < 0.001) and percent (ρleft = -0.249, p < 0.001; ρright = -0.098, p = 0.102) changes in HAMD-17 score. The sweet spot model of HAMD-17 improvement also suggested that the VTA overlap with the dorsal side of BNST was associated with the impact on depressive symptoms (t = -4.10, p < 0.05). CONCLUSIONS: Combined BNST-NAc stimulation of TRD can effectively improve depressive symptoms, in which the BNST seems to have a dominant therapeutic effect. The results of this study not only help to optimize the DBS programming parameters, but also offer an opportunity to further understand the differences between the two targets. In the future, larger prospective cohorts are needed to verify the results of combined BNST-NAc DBS.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Wang T, Dai L, Lai Y, et al. Parameter-based analysis of clinical efficacy of combined bed nucleus of the stria terminalis-nucleus accumbens deep brain stimulation for treatment-resistant depression. J Neurosurg. 2024. PMID: 38215436. doi:10.3171/2023.10.JNS231855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。